To tell or not to tell: why people with HIV share or don't share with their physicians whether they are taking their medications as prescribed

AIDS Care. 2006 Jul;18(5):520-8. doi: 10.1080/09540120600766020.

Abstract

This qualitative study examines whether HIV-positive people (N = 79) tell their physicians whether they take antiretroviral treatment (ART) as prescribed and why. Interviews, analyzed with qualitative content-analysis, asked about taking/not taking ART and, if taking, whether they shared their reasons for non-adherence with their physician. Patients are more likely to inform physicians why they take than why they do not take ART (p<0.01). Only half of those not taking ART shared the reasons for their decision with their physician. The six motives were: anticipation that physicians will not support the decision, cannot discuss feelings, lack of trust in physician's opinion, unable to discuss spiritual/moral issues, no need for physician to know, and not seen physician yet. Of those taking ART, 21% did not tell their physician why they missed doses. The five motives were: not viewed as important, physician not asking, not seen physician yet, rarely non-adherent, no indications in surrogate markers. A significant proportion of patients are not taking their medications as prescribed and are not telling their physicians. To facilitate the chance that patients communicate with their physicians, physicians need to ask no need for and, while giving the patients medical information, create a non-judgmental, respectful atmosphere where patients feel comfortable sharing their personal view.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Anti-Retroviral Agents / therapeutic use
  • Decision Making
  • Female
  • Florida
  • HIV Infections / drug therapy
  • HIV Infections / psychology*
  • Humans
  • Longitudinal Studies
  • Male
  • Motivation
  • Patient Compliance*
  • Physician-Patient Relations
  • Sexual Behavior
  • Surveys and Questionnaires
  • Truth Disclosure*

Substances

  • Anti-HIV Agents
  • Anti-Retroviral Agents